EMPLOYMENT AGREEMENTEmployment Agreement • March 1st, 2010 • Warner Chilcott PLC • Pharmaceutical preparations • New Jersey
THIS EMPLOYMENT AGREEMENT (the “Agreement”) is made as of October 20, 2009, between WARNER CHILCOTT (US), LLC (the “Company”), and Mahdi Fawzi, Ph.D. (“Executive”).
WARNER CHILCOTT EQUITY INCENTIVE PLAN RESTRICTED SHARE UNIT AWARD AGREEMENTEquity Incentive Plan • March 1st, 2010 • Warner Chilcott PLC • Pharmaceutical preparations • New York
You have been granted a Restricted Share Unit Award on the following terms and subject to the provisions of the Restricted Share Unit Award Agreement Terms and Conditions (“Attachment A”) appended hereto and the Warner Chilcott Equity Incentive Plan, as amended and restated (the “Plan”). Unless defined in this Restricted Share Unit Award Agreement (together with Attachment A and each annex thereto, the “Agreement”), capitalized terms will have the meanings ascribed to them in the Plan. In the event of a conflict among the provisions of the Plan, this Agreement and any descriptive materials provided to you, the provisions of the Plan will prevail.
WARNER CHILCOTT EQUITY INCENTIVE PLAN RESTRICTED SHARE AWARD AGREEMENTEquity Incentive Plan • March 1st, 2010 • Warner Chilcott PLC • Pharmaceutical preparations • New York
You have been granted a restricted share award (the “Restricted Share Award”) on the following terms and subject to the provisions of the Share Award Agreement Terms and Conditions (“Attachment A”) appended hereto and the Warner Chilcott Equity Incentive Plan, as amended and restated (the “Plan”). Unless defined in this Restricted Share Award Agreement (together with Attachment A and each annex thereto, the “Agreement”), capitalized terms will have the meanings ascribed to them in the Plan. In the event of a conflict among the provisions of the Plan, this Agreement and any descriptive materials provided to you, the provisions of the Plan will prevail.
Transition Services Agreement by and between The Procter & Gamble Company and Company Effective as of October 30, 2009Transition Services Agreement • March 1st, 2010 • Warner Chilcott PLC • Pharmaceutical preparations • New York
This Transition Services Agreement (this “Agreement”) is entered into effective October 30, 2009 (the “Effective Date”) by and between Warner Chilcott plc, a public limited company organized under the laws of Ireland (“Customer”) and The Procter & Gamble Company, an Ohio corporation (“Service Provider”).
WARNER CHILCOTT EQUITY INCENTIVE PLAN SHARE OPTION AWARD AGREEMENTEquity Incentive Plan • March 1st, 2010 • Warner Chilcott PLC • Pharmaceutical preparations • New York
You have been granted an Option (the “Option”) on the following terms and subject to the provisions of the Share Option Award Agreement Terms and Conditions (“Attachment A”) appended hereto and the Warner Chilcott Equity Incentive Plan, as amended and restated (the “Plan”). Unless defined in this Share Option Award Agreement (together with Attachment A and each annex and exhibit thereto, the “Agreement”), capitalized terms will have the meanings ascribed to them in the Plan. In the event of a conflict among the provisions of the Plan, this Agreement and any descriptive materials provided to you, the provisions of the Plan will prevail.
Amendment AgreementAmendment Agreement • March 1st, 2010 • Warner Chilcott PLC • Pharmaceutical preparations
This Amendment Agreement (“Agreement”) dated December 19, 2007 (the “Effective Date”) is by and between The Procter & Gamble Company, Procter & Gamble Pharmaceuticals, Inc. (collectively, “P&G”) and Sanofi-Aventis U.S. LLC (“S-A”), (individually P&G and S-A may also be referred to herein as “Party” and collectively as the “Parties”).
CONFIDENTIAL TREATMENT REQUESTED UNDERCollaboration Agreement • March 1st, 2010 • Warner Chilcott PLC • Pharmaceutical preparations • Ohio
CONFIDENTIAL TREATMENT REQUESTED UNDERWarner Chilcott PLC • March 1st, 2010 • Pharmaceutical preparations
